International Review of Ophthalmology

Previous Articles     Next Articles

Research progress on canaloplasty

ZHANG Jun1, WANG Huai-zhou2, WANG Ning-li2.   

  1. 1. Dalian Aier Eye Hospital, Dalian 116031, China; 2. Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing Tongren Hospital, Capital Medical University, Beijing 100005, China
  • Received:2018-01-30 Online:2018-04-22 Published:2018-05-04
  • Contact: ZHANG Jun, Email:30539031@qq.com

Abstract:

As a non-penetrating glaucoma surgery (NPGS), canaloplasty aims to restore the physiological outflow by dilating the Schlemm’s canal, thus facilitating aqueous outflow to treat glaucoma. Evolving from traditional canaloplasty, ab-interno canaloplasty (ABiC) is a new minimally invasive glaucoma surgery (MIGS) procedure that can comprehensively restore the natural outflow pathways in patients with mild-to-moderate primary open angle glaucoma. Canaloplasty represent a truly effective and excellent safety profile for reducing intraocular pressure with or without combining with other surgeries. Canaloplasty is non-bleb related with no filtering blebs which were detected a low rate of bleb-related complications such as scar formation and encapsulation. Canaloplasty has satisfactory intraocular pressure lowering effects in high efficiency and security. (Int Rev Ophthalmol, 2018, 42: 78-82)